Oral Cancer Risk Factor Quantifier
An interactive tool that quantifies cumulative risk based on patient-specific exposures, habits, and demographics.
| Factor | Relative Risk | Mechanism | Key Evidence |
|---|---|---|---|
| Tobacco (smoked) | 6-10x | Polycyclic aromatic hydrocarbons and nitrosamines cause DNA adducts, p53 mutations, CDKN2A inactivation. Field cancerization: the entire mucosal field is damaged, explaining multifocal lesions and second primary tumors | IARC Group 1 carcinogen. Risk increases with duration and intensity. Risk decreases after cessation but never returns to baseline for heavy smokers |
| Tobacco + alcohol | Up to 30x (multiplicative) | Alcohol acts as a solvent, increasing mucosal permeability to tobacco carcinogens. Acetaldehyde (alcohol metabolite) is itself a carcinogen. The combination is MULTIPLICATIVE, not additive | Hashibe 2009 pooled analysis: combined tobacco + alcohol accounts for 72% of oral/pharyngeal cancers in Western populations |
| Betel / areca nut | 5-8x | Arecoline generates reactive oxygen species. Causes OSMF (submucosal fibrosis) which has 7-13% transformation rate. Nitrosamines from the betel nut are directly carcinogenic | IARC Group 1 carcinogen. Leading cause of oral cancer in South/Southeast Asia. Betel quid with tobacco: 10-15x risk |
| HPV-16 | 3-5x (oropharyngeal) | HPV E6/E7 oncoproteins inactivate p53 and Rb tumor suppressors. Primarily drives OROPHARYNGEAL SCC (tonsil, base of tongue), not oral cavity SCC. The epidemiology has shifted: HPV+ oropharyngeal cancer now exceeds HPV- in Western countries | HPV+ oropharyngeal SCC: 80-90% 5-year survival (much better than HPV-). AJCC 8th Ed created SEPARATE staging for HPV+ oropharyngeal to reflect this different biology |
| Chronic UV (lip) | 3-5x | Cumulative UV-B damage to the lower lip vermilion. Actinic cheilitis is the premalignant stage. Lower lip SCC accounts for 25-30% of all lip cancers | Outdoor workers (farmers, construction). Fair-skinned populations. Lip SPF protection reduces risk |
Clinical Presentation of Early-Stage Carcinoma
Early oral SCC is often asymptomatic, subtle, and easily mistaken for benign conditions. Recognizing the early clinical features saves lives.
Epithelial Dysplasia Grading
Dysplasia is the histological hallmark of premalignancy. Its grade predicts transformation risk and guides management.
TNM Staging Interactive Explorer
AJCC 8th Edition (2017) staging for oral cavity squamous cell carcinoma, with the landmark addition of depth of invasion (DOI).
Survival Outcomes Calculator
Estimated 5-year survival based on stage, site, HPV status, and treatment modality.
12 Case Scenarios
Biopsy findings, staging, and complete treatment planning from early dysplasia through advanced carcinoma.
Guidelines & Evidence
DIDACTIC MED
Malignancy Risk Assessment & Early Detection
References: NCCN 2024 • WHO 2022 • AJCC 8th Ed • CDC Oral Cancer • Warnakulasuriya 2018
For educational purposes only. © Didactic Med 2025